A 38-year-old woman from Mumbai with chronic renal disease (eGFR 18 mL/min) presents with progressive muscle weakness, fatigue, and a serum potassium of 6.8 mEq/L. ECG shows peaked T waves and a prolonged PR interval. She is haemodynamically stable with no acute symptoms. Which of the following is the most appropriate next step in management?

Explanation

## Clinical Context This patient has **severe hyperkalemia (K⁺ = 6.8 mEq/L)** with **ECG changes** (peaked T waves, prolonged PR interval) in the setting of advanced CKD (eGFR 18 mL/min). Although she is haemodynamically stable, the presence of ECG changes indicates **cardiac membrane instability** requiring **immediate cardioprotection** as the first step. ## Pathophysiology: Why ECG Changes Demand Immediate Action **Key Point:** The resting membrane potential (RMP) is governed by the ratio of extracellular to intracellular K⁺ (Nernst equation). Elevated extracellular K⁺ depolarizes the RMP, reducing the threshold for action potential generation and causing: 1. **Peaked T waves** → enhanced repolarization (early sign) 2. **Prolonged PR interval** → impaired AV conduction 3. **Risk of progression** → wide QRS, sine wave pattern, ventricular fibrillation $$E_K = 61.5 \log \frac{[K^+]_{out}}{[K^+]_{in}}$$ Even in chronic CKD, once ECG changes appear, the **immediate priority is cardiac membrane stabilization**, regardless of hemodynamic stability. ## Why Calcium Gluconate Is the Correct First Step **IV Calcium Gluconate 10%** is the **most appropriate next step** because: 1. **Mechanism:** Calcium raises the threshold potential, restoring the gap between RMP and threshold — it **directly antagonizes** the cardiac membrane effects of hyperkalemia without altering serum K⁺ 2. **Onset:** Within **1–3 minutes** — the fastest-acting intervention available 3. **Indication:** Any hyperkalemia with ECG changes, regardless of whether the patient is acutely symptomatic or hemodynamically stable 4. **Safety:** Transient effect (~30–60 min), allowing time for definitive K⁺-lowering measures to follow 5. **Standard of care:** Per Harrison's Principles of Internal Medicine and UpToDate guidelines, calcium gluconate is indicated for **K⁺ > 6.5 mEq/L with ECG changes** as the immediate first step **Clinical Pearl (Harrison's):** "Calcium gluconate should be given immediately when ECG changes are present in hyperkalemia, as it protects the heart while other measures are initiated to lower serum potassium." ## Sequence of Management After Calcium Gluconate Following cardiac stabilization with calcium gluconate, the next steps are: | Step | Intervention | Onset | Mechanism | |---|---|---|---| | **1 (Immediate)** | IV Calcium gluconate | 1–3 min | Membrane stabilization | | **2 (Shift)** | Insulin + Dextrose | 15–30 min | Drives K⁺ intracellularly | | **3 (Remove)** | Haemodialysis | Hours | Definitive K⁺ removal | | **4 (Adjunct)** | Cation exchange resin | 2–12 hrs | GI K⁺ removal | ## Why the Other Options Are Incorrect - **Option A (Sodium polystyrene sulfonate + dialysis in 24 hrs):** Resin onset is 2–12 hours — too slow as the *first* step when ECG changes are already present. Dialysis within 24 hours is appropriate but not the *immediate* next step. - **Option B (IV sodium bicarbonate):** Bicarbonate shifts K⁺ intracellularly but does NOT stabilize the cardiac membrane. It is a secondary measure and less effective than insulin/dextrose. It is not the first step. - **Option C (Furosemide IV):** Loop diuretics are largely ineffective at eGFR 18 mL/min (advanced CKD). Observing for 2 hours with active ECG changes is inappropriate and dangerous. ## Management Algorithm ``` Hyperkalemia K⁺ = 6.8 + ECG changes ↓ IMMEDIATE: IV Calcium Gluconate (cardiac membrane stabilization) ↓ SHIFT: Insulin + Dextrose (± Sodium Bicarbonate) ↓ REMOVE: Urgent Haemodialysis (definitive in CKD) ↓ PREVENT: Dietary K⁺ restriction + Nephrology follow-up ``` **High-Yield Mnemonic — "C-BIG-K-Drop":** **C**alcium → **B**icarbonate → **I**nsulin/**G**lucose → **K**ayexalate/dialysis **Reference:** Harrison's Principles of Internal Medicine, 21st ed., Chapter on Fluid and Electrolyte Disorders; Marino's The ICU Book, 4th ed.